Pacific Biosciences of California.../ US69404D1081 /
20/09/2024 22:00:00 | Chg. -0.2150 | Volume | Bid01:59:57 | Ask01:59:57 | High | Low |
---|---|---|---|---|---|---|
1.8250USD | -10.54% | 11.13 mill. Turnover: 20.07 mill. |
1.8300Bid Size: 100 | 1.9200Ask Size: 400 | 2.0100 | 1.7900 |
GlobeNewswire
26/08
PacBio to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference
GlobeNewswire
05/08
Singapore’s National Precision Medicine (NPM) programme will partner with PacBio to propel HiFi Sequ...
GlobeNewswire
23/07
Novogene to Power Cancer, Rare Disease, and Environmental Research with PacBio Sequencing
GlobeNewswire
28/02/2022
PacBio Supports SickKids to Investigate Use of HiFi Sequencing in Undiagnosed Genetic Conditions
GlobeNewswire
16/02/2022
KK Women’s and Children’s Hospital and PacBio Collaborate in Asia’s First Study of Unexplained Neuro...
GlobeNewswire
01/02/2022
PacBio to Report Fourth Quarter and Full Year 2021 Financial Results on February 15, 2022
GlobeNewswire
13/01/2022
PacBio Names Lara Toerien as Vice President and General Manager for the Americas
GlobeNewswire
11/01/2022
PacBio and Berry Genomics Announce Collaboration to Bring Long Read Desktop Sequencing Instrument to...
GlobeNewswire
11/01/2022
PacBio Announces Collaboration with Genomics England to Sequence Biobanked Rare Disease Samples Usin...
GlobeNewswire
11/01/2022
PacBio and Google Collaborate to Use Machine Learning to Optimize Long-Read Sequencing Data Analysis
GlobeNewswire
11/01/2022
PacBio Announces Record Preliminary Fourth Quarter 2021 Revenue, New Sequencing Kits and Workflows, ...
GlobeNewswire
07/12/2021
PacBio and UCLA Health Announce Research Collaboration for Whole Genome Sequencing in Rare Diseases